When patients stop taking vismodegib, basal cell tumors often grow back.
Credit
Michigan Medicine
Usage Restrictions
for use in stories about this research
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.